• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    BELLUS Health Inc. - Common Shares (NQ: BLU )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Jun 28, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about BELLUS Health Inc. - Common Shares

    < Previous 1 2 3 4 Next >
    The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    BELLUS Health Reports First Quarter 2022 Financial Results and Business Highlights
    From BELLUS Health Inc.
    Via Business Wire
    BELLUS Health to Present Late-Breaking Clinical Data from the Phase 2b SOOTHE Trial of BLU-5937 at the ATS 2022 International Conference
    From BELLUS Health Inc.
    Via Business Wire
    BELLUS Health to Participate in Multiple Upcoming Investor Conferences
    From BELLUS Health Inc.
    Via Business Wire
    BELLUS Health Reports Year 2021 Financial Results and Business Highlights
    From BELLUS Health Inc.
    Via Business Wire
    BELLUS Health Closes US$200 Million Public Offering of Common Shares in Canada and the United States
    From BELLUS Health Inc.
    Via Business Wire
    BELLUS Health Announces Pricing of US$200 Million Public Offering in Canada and the United States
    From BELLUS Health Inc.
    Via Business Wire
    The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Vaccitech To Buy Avidea For $40M Vaccitech plc (NASDAQ: VACC) announced that... 
    Via Benzinga
    BELLUS Health Announces the Launch of a Public Offering of Common Shares in Canada and the United States
    From BELLUS Health Inc.
    Via Business Wire
    58 Biggest Movers From Yesterday
    Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares jumped 80.4% to close at $90.08 on Monday. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-... 
    Via Benzinga
    Mid-Afternoon Market Update: Dow Tumbles Over 200 Points; BELLUS Health Shares Spike Higher
    Toward the end of trading Monday, the Dow traded down 0.67% to 35,728.62 while the NASDAQ fell 0.92% to 15,487.41. The S&P also fell, dropping 0.58% to 4,684.47. The U.S. has... 
    Via Benzinga
    Mid-Day Market Update: Nasdaq Drops Over 100 Points; Foghorn Therapeutics Shares Surge
    Midway through trading Monday, the Dow traded down 0.81% to 35,679.10 while the NASDAQ fell 0.78% to 15,509.01. The S&P also fell, dropping 0.67% to 4,680.56. The U.S. has the... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    40 Stocks Moving In Monday's Mid-Day Session
    Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction.... 
    Via Benzinga
    ARNA Stock Alert: The Pfizer Deal That Has Arena Pharmaceuticals Rocketing Today
    Arena Pharmaceuticals (ARNA) stock is flying higher on Monday thanks to a huge $6.7 billion acquisition deal with Pfizer (PFE). 
    Via InvestorPlace
    Here's Why Bellus Health Is Jumping Higher Today
    A phase 2 trial with the company's chronic-cough candidate hit its primary endpoint. 
    Via The Motley Fool
    NES, WTTR: The Deal That Has Penny Stock Nuverra Environmental Solutions Skyrocketing Today
    Nuverra Environmental (NES) stock is surging higher on Monday following news of a massive deal with Select Energy Services (WTTR). 
    Via InvestorPlace
    BLU Stock Alert: The Study Data That Has BELLUS Health Blasting Higher Today
    BELLUS Health (BLU) stock is rocketing higher on Monday and it's all thanks to data from a Phase 2b clinical trial of BLU-5937. 
    Via InvestorPlace
    Mid-Morning Market Update: Markets Open Lower; Pfizer To Acquire Arena Pharmaceuticals
    Following the market opening Monday, the Dow traded down 0.65% to 35,736.04 while the NASDAQ fell 0.26% to 15,590.13. The S&P also fell, dropping 0.46% to 4,690.48. The U.S.... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
    From BELLUS Health Inc.
    Via Business Wire
    The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Acadia Announces Positive Phase 3 Data For Trofinetide In Rett Syndrome... 
    Via Benzinga
    BELLUS Health Reports Third Quarter 2021 Financial Results and Business Highlights
    From BELLUS Health Inc.
    Via Business Wire
    BELLUS Health to Participate in Two Upcoming Healthcare Investor Conferences
    From BELLUS Health Inc.
    Via Business Wire
    BELLUS Health Convenes Virtual Analyst Event to Discuss the Chronic Cough Landscape and its Selective P2X3 Antagonist BLU-5937
    From BELLUS Health Inc.
    Via Business Wire
    BELLUS Health Announces Completion of Patient Enrollment in SOOTHE Phase 2b Trial for Refractory Chronic Cough and BLUEPRINT Phase 2a Trial for Chronic Pruritus Associated with Atopic Dermatitis
    From BELLUS Health Inc.
    Via Business Wire
    The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
    Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks... 
    Via Benzinga
    Exposures Product Safety
    46 Biggest Movers From Yesterday
    Gainers Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special dividend of $3.50 per share. Onion Global Limited... 
    Via Benzinga
    The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)... 
    Via Benzinga
    Exposures COVID-19
    Why BELLUS Health Is Trading Higher Today
    BELLUS Health (NASDAQ:BLU) shares are trading higher. The company on Monday announced interim analysis from the Phase 2b SOOTHE trial of BLU-5937 in refractor chronic... 
    Via Benzinga
    Mid-Afternoon Market Update: Dow Tumbles 300 Points; Communications Systems Shares Climb
    Toward the end of trading Tuesday, the Dow traded down 0.87% to 34,565.88 while the NASDAQ fell 0.46% to 15,035.39. The S&P also fell, dropping 0.60% to 4,441.76. The U.S. has... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Mid-Day Market Update: FuelCell Energy Jumps After Q3 Results; RedHill Biopharma Shares Slide
    Midway through trading Tuesday, the Dow traded down 0.49% to 34,698.16 while the NASDAQ fell 0.05% to 15,098.38. The S&P also fell, dropping 0.24% to 4,458.05. The U.S. has... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    < Previous 1 2 3 4 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.